BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.29.0//EN
X-ORIGINAL-URL:https://terkko.fi/
X-WR-CALNAME:Terkko Health Hub
X-WR-CALDESC:Hub for Health & Life Sciences Entrepreneurship
X-WR-TIMEZONE:Europe/Helsinki
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
X-LIC-LOCATION:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20260329T040000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20261025T030000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=4SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-0913e2e6049a59306f85c213277a5253@terkko.fi
DTSTART;TZID=Europe/Helsinki:20251204T110000
DTEND;TZID=Europe/Helsinki:20251204T130000
DTSTAMP:20251031T093917Z
CREATED:20251031
LAST-MODIFIED:20251031
PRIORITY:5
SEQUENCE:0
TRANSP:OPAQUE
SUMMARY:Translating Proteomic Insights into Clinical Outcome Prediction
DESCRIPTION:Organiser: Standard Biotools\nEvent description: The event is a workshop/seminar about using proteomic data and machine learning algorithms to predict risk of diseases. I will show that some of these models are already being used in clinical trials. One such example is the study with semaglutide which shows positive effect on cardiometabolic health on the proteome level. This can be translated into smarter and smaller trials as well as shortening the time to get drugs on the market. We will also show anyone that has an interest how they can get access to public data from different population studies around the world and can use that data to build their own predictive models or understand the underlying biology of a specific disease. The event is open to anyone who has an interest in drug development, machine learning in healthcare, epidemiology and computational biology.\nWho is your event aimed at? Why is the event good for them?\nTo those in your hub that is working on drug development and especially if they are working with cardiometabolic diseases, cancer or neurodegenerative diseases but also to the scientists around the area that is working with machine learning in biology.\nVenue: Helsinki Think Company Cube\n
URL:https://terkko.fi/events/translating-proteomic-insights-into-clinical-outcome-prediction/
LOCATION:Terkko Health Hub, Haartmaninkatu 4, Building 14, 00290 Helsinki, Suomi
END:VEVENT
END:VCALENDAR